Home LiteratureArticle Details
PMID: 12716455 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Tissue distribution of migration inhibitory factor and inducible nitric oxide synthase in falciparum malaria and sepsis in African children.

Malaria journal ·Vol. 2 ·2003-04-08 ·Pages 6

Clark IA, Awburn MM, Whitten RO, Harper CG, Liomba NG, Molyneux ME, Taylor TE

Abstract

The inflammatory nature of falciparum malaria has been acknowledged since increased circulating levels of tumour necrosis factor (TNF) were first measured, but precisely where the mediators downstream from this prototype inflammatory mediator are generated has not been investigated. Here we report on the cellular distribution, by immunohistochemistry, of migration inhibitory factor (MIF) and inducible nitric oxide synthase (iNOS) in this disease, and in sepsis. We stained for MIF and iNOS in tissues collected during 44 paediatric autopsies in Blantyre, Malawi. These comprised 42 acutely ill comatose patients, 32 of whom were diagnosed clinically as cerebral malaria and the other 10 as non-malarial diseases. Another 2 were non-malarial, non-comatose deaths. Other control tissues were from Australian adults. Of the 32 clinically diagnosed cerebral malaria cases, 11 had negligible histological change in the brain, and no or scanty intravascular sequestration of parasitised erythrocytes, another 7 had no histological changes in the brain, but sequestered parasitised erythrocytes were present (usually dense), and the remaining 14 brains showed micro-haemorrhages and intravascular mononuclear cell accumulations, plus sequestered parasitised erythrocytes. The vascular walls of the latter group stained most strongly for iNOS. Vascular wall iNOS staining was usually of low intensity in the second group (7 brains) and was virtually absent from the cerebral vascular walls of 8 of the 10 comatose patients without malaria, and also from control brains. The chest wall was chosen as a typical non-cerebral site encompassing a range of tissues of interest. Here pronounced iNOS staining in vascular wall and skeletal muscle was present in some 50% of the children in all groups, including septic meningitis, irrespective of the degree of staining in cerebral vascular walls. Parasites or malarial pigment were rare to absent in all chest wall sections. While MIF was common in chest wall vessels, usually in association with iNOS, it was absent in brain vessels. These results agree with the view that clinically diagnosed cerebral malaria in African children is a collection of overlapping syndromes acting through different organ systems, with several mechanisms, not necessarily associated with cerebral vascular inflammation and damage, combining to cause death.

MeSH Terms
Adult Africa/epidemiology Animals Child Child, Preschool Female Humans Immunohistochemistry Infant Macrophage Migration-Inhibitory Factors/immunology,metabolism Malaria, Cerebral/enzymology,epidemiology,metabolism Malaria, Falciparum/enzymology,epidemiology,metabolism Male Nitric Oxide Synthase/metabolism Nitric Oxide Synthase Type II Plasmodium falciparum/isolation & purification Sepsis/enzymology,metabolism Telencephalon/chemistry,pathology Tissue Distribution
Chemicals
Macrophage Migration-Inhibitory Factors NOS2 protein, human Nitric Oxide Synthase Nitric Oxide Synthase Type II
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Clark Ian A
Dept of Biochemistry, Australian National University, Canberra, Australia. [email protected]
Awburn Melissa M
Whitten Richard O
Harper Clive G
Liomba N George
Molyneux Malcolm E
Taylor Terrie E
References (73)
73 references, click to expand
  1. Protection from septic shock by neutralization of macrophage migration inhibitory factor.
    Nat Med. 2000 Feb;6(2):164-70 PMID: 10655104
  2. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor.
    J Exp Med. 1994 Jun 1;179(6):1895-902 PMID: 8195715
  3. Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness.
    J Clin Endocrinol Metab. 2001 Jun;86(6):2811-6 PMID: 11397892
  4. Nitric oxide synthase activity endogenously modulates NMDA receptors.
    J Neurochem. 1993 Jul;61(1):368-70 PMID: 7685816
  5. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels.
    Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2479-88 PMID: 9409218
  6. Vascular effects of LPS in mice deficient in expression of the gene for inducible nitric oxide synthase.
    Am J Physiol. 1998 Aug;275(2 Pt 2):H416-21 PMID: 9683428
  7. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria.
    J Infect Dis. 1996 Nov;174(5):1091-7 PMID: 8896514
  8. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha.
    N Engl J Med. 1996 Aug 1;335(5):311-5 PMID: 8663853
  9. What's new in the cerebral microcirculation? Landis Award lecture.
    Microcirculation. 2001 Dec;8(6):365-75 PMID: 11781810
  10. Constitutive expression and structural diversity of inducible isoform of nitric oxide synthase in human tissues.
    Life Sci. 1996;59(3):219-25 PMID: 8699932
  11. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria.
    Am J Med. 1989 Aug;87(2):139-43 PMID: 2667356
  12. Axonal injury in cerebral malaria.
    Am J Pathol. 2002 Feb;160(2):655-66 PMID: 11839586
  13. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study.
    J Natl Cancer Inst. 1988 Sep 7;80(13):1039-44 PMID: 3411618
  14. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.
    Lancet. 1990 Nov 17;336(8725):1201-4 PMID: 1978068
  15. Possible importance of macrophage-derived mediators in acute malaria.
    Infect Immun. 1981 Jun;32(3):1058-66 PMID: 6166564
  16. Malaria: macrophage migration inhibition factor (MIF).
    J Parasitol. 1976 Feb;62(1):137-8 PMID: 768434
  17. Nitric oxide and parasitic disease.
    Adv Parasitol. 1996;37:1-56 PMID: 8881597
  18. Proposed link between cytokines, nitric oxide and human cerebral malaria.
    Parasitol Today. 1991 Aug;7(8):205-7 PMID: 15463497
  19. Possible central role of nitric oxide in conditions clinically similar to cerebral malaria.
    Lancet. 1992 Oct 10;340(8824):894-6 PMID: 1383658
  20. Expression of nitric oxide synthase in human central nervous system tumors.
    Cancer Res. 1995 Feb 15;55(4):727-30 PMID: 7531613
  21. Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis.
    Intensive Care Med. 2001 Aug;27(8):1412-5 PMID: 11511957
  22. Presence of macrophage migration inhibitory factor (MIF) in ependyma, astrocytes and neurons in the bovine brain.
    Neurosci Lett. 1996 Aug 9;213(3):193-6 PMID: 8873147
  23. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.
    Science. 1966 Jul 1;153(3731):80-2 PMID: 5938421
  24. Association between mitochondrial dysfunction and severity and outcome of septic shock.
    Lancet. 2002 Jul 20;360(9328):219-23 PMID: 12133657
  25. Suggested importance of monokines in pathophysiology of endotoxin shock and malaria.
    Klin Wochenschr. 1982 Jul 15;60(14):756-8 PMID: 6181289
  26. Nitric oxides in plasma, urine, and cerebrospinal fluid in patients with severe falciparum malaria.
    Am J Trop Med Hyg. 1998 Sep;59(3):497-502 PMID: 9749651
  27. Migration inhibitory factor expression in experimentally induced endotoxemia.
    Am J Pathol. 1997 Jan;150(1):235-46 PMID: 9006339
  28. Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria.
    Am J Trop Med Hyg. 1994 Nov;51(5):642-7 PMID: 7985757
  29. Indicators of life-threatening malaria in African children.
    N Engl J Med. 1995 May 25;332(21):1399-404 PMID: 7723795
  30. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain.
    Am J Pathol. 1999 Aug;155(2):395-410 PMID: 10433933
  31. Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock.
    J Inflamm. 1995-1996;47(1-2):39-51 PMID: 8913928
  32. Endogenous and exogenous nitric oxide in the pedunculopontine tegmentum induces sleep.
    Synapse. 1997 Sep;27(1):69-78 PMID: 9268066
  33. The pathogenesis of severe malaria in African children.
    Ann Trop Med Parasitol. 1996 Aug;90(4):395-402 PMID: 8944083
  34. Induction of diaphragmatic nitric oxide synthase after endotoxin administration in rats: role on diaphragmatic contractile dysfunction.
    J Clin Invest. 1996 Oct 1;98(7):1550-9 PMID: 8833903
  35. Autocrine inhibition of Na+/K(+)-ATPase by nitric oxide in mouse proximal tubule epithelial cells.
    J Clin Invest. 1995 May;95(5):2083-8 PMID: 7537754
  36. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha.
    J Immunol. 1998 Sep 1;161(5):2383-90 PMID: 9725234
  37. Reactive nitrogen intermediates and outcome in severe adult malaria.
    Trans R Soc Trop Med Hyg. 1998 Mar-Apr;92(2):170-5 PMID: 9764323
  38. Acid-base status in paediatric Plasmodium falciparum malaria.
    Q J Med. 1993 Feb;86(2):99-109 PMID: 8464997
  39. Is nitric oxide overproduction the target of choice for the management of septic shock?
    Pharmacol Ther. 2001 Sep;91(3):179-213 PMID: 11744067
  40. Absence of the inducible form of nitric oxide synthase in the brains of patients with the acquired immunodeficiency syndrome.
    J Neurovirol. 1997 Apr;3(2):153-67 PMID: 9111178
  41. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide.
    Cytokine. 1998 Mar;10(3):199-205 PMID: 9576065
  42. Muscular contractile failure in septic patients: role of the inducible nitric oxide synthase pathway.
    Am J Respir Crit Care Med. 2000 Dec;162(6):2308-15 PMID: 11112156
  43. Roles of tumour necrosis factor in the illness and pathology of malaria.
    Trans R Soc Trop Med Hyg. 1989 Jul-Aug;83(4):436-40 PMID: 2694475
  44. Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria.
    Trans R Soc Trop Med Hyg. 1993 Jul-Aug;87(4):436-43 PMID: 8249075
  45. Inhibition of nitric oxide synthesis induces a significant reduction in local cerebral blood flow in the rat.
    Neurosci Lett. 1991 Jun 10;127(1):129-32 PMID: 1881609
  46. Tumor necrosis factor and disease severity in children with falciparum malaria.
    N Engl J Med. 1989 Jun 15;320(24):1586-91 PMID: 2657427
  47. Nitric oxide stimulates guanylate cyclase and regulates sodium transport in rabbit proximal tubule.
    Am J Physiol. 1996 Jan;270(1 Pt 2):F106-15 PMID: 8769828
  48. Plasma nitrogen oxides and blood lactate concentrations in Ghanaian children with malaria.
    Trans R Soc Trop Med Hyg. 1997 May-Jun;91(3):298-302 PMID: 9231201
  49. The role of nitric oxide in sepsis--an overview.
    Acta Anaesthesiol Scand. 1999 Mar;43(3):275-88 PMID: 10081533
  50. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids.
    Arthritis Rheum. 1999 Aug;42(8):1601-8 PMID: 10446857
  51. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children.
    Lancet. 2002 Nov 9;360(9344):1468-75 PMID: 12433515
  52. Migration inhibitory factor in the cerebral and systemic endothelium in sepsis and malaria.
    Crit Care Med. 2002 May;30(5 Suppl):S263-7 PMID: 12004246
  53. Host-parasite interaction and morbidity in malaria endemic areas.
    Philos Trans R Soc Lond B Biol Sci. 1997 Sep 29;352(1359):1385-94 PMID: 9355131
  54. The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle.
    J Clin Invest. 2000 Nov;106(10):1291-300 PMID: 11086030
  55. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis.
    Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12041-5 PMID: 8618840
  56. Macrophage migration inhibitory factor in the human endometrium: expression and localization during the menstrual cycle and early pregnancy.
    Biol Reprod. 2001 Apr;64(4):1200-5 PMID: 11259268
  57. Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia.
    Infect Immun. 2000 Apr;68(4):2259-67 PMID: 10722628
  58. Cerebral blood flow during experimental endotoxemia in volunteers.
    Crit Care Med. 1997 Oct;25(10):1700-6 PMID: 9377885
  59. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia.
    Stroke. 1996 Aug;27(8):1373-80 PMID: 8711805
  60. Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung.
    Cancer. 2000 Jul 15;89(2):334-41 PMID: 10918163
  61. Inducible nitric oxide synthase expression is increased in the brain in fatal cerebral malaria.
    Histopathology. 2000 Sep;37(3):269-77 PMID: 10971704
  62. Possible role of nitric oxide in malarial immunosuppression.
    Parasite Immunol. 1994 May;16(5):243-9 PMID: 8072768
  63. Malaria parasite-specific Th1-like T cells simultaneously reduce parasitemia and promote disease.
    Parasite Immunol. 1999 Jun;21(6):319-29 PMID: 10354354
  64. Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide.
    Neuroreport. 1996 Sep 2;7(13):2181-5 PMID: 8930985
  65. Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation.
    Am J Pathol. 2001 Oct;159(4):1199-209 PMID: 11583946
  66. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
    Mol Pharmacol. 1996 Jan;49(1):15-21 PMID: 8569701
  67. The biological basis of malarial disease.
    Int J Parasitol. 1997 Oct;27(10):1237-49 PMID: 9394194
  68. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo.
    Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7809-13 PMID: 7544004
  69. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.
    Proc Natl Acad Sci U S A. 1966 Jul;56(1):72-7 PMID: 5229858
  70. Identification and immunohistochemical localization of macrophage migration inhibitory factor in human kidney.
    Biochem Mol Biol Int. 1996 Dec;40(6):1233-42 PMID: 8988336
  71. The cytokine theory of human cerebral malaria.
    Parasitol Today. 1994 Oct;10(10):410-2 PMID: 15275552
  72. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.
    Nature. 1993 Oct 21;365(6448):756-9 PMID: 8413654
  73. Serum tumor necrosis factor associated with malaria in patients in the Solomon Islands.
    Trans R Soc Trop Med Hyg. 1990 Sep-Oct;84(5):658-61 PMID: 2126152
Article Info
Journal
Malaria journal
Abbr.
Malar J
ISSN
1475-2875
Published
2003-04-08
Epub
2003-00-08
Pages
6
Language
English
Region
England
NLM ID
101139802
PMCID
PMC154094
Subset
IM
Grants
NIAID NIH HHS · R01 AI034969 · United States
NIAID NIH HHS · 1-R01-AI 34969 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]